Stocks and Investing
Stocks and Investing
Wed, November 8, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, November 7, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Nathan Rich Maintained (XRAY) at Hold with Decreased Target to $36 on, Nov 7th, 2023
Nathan Rich of Goldman Sachs, Maintained "DENTSPLY SIRONA Inc." (XRAY) at Hold with Decreased Target from $42 to $36 on, Nov 7th, 2023.
Nathan has made no other calls on XRAY in the last 4 months.
There are 4 other peers that have a rating on XRAY. Out of the 4 peers that are also analyzing XRAY, 2 agree with Nathan's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jonathan Block of "Stifel" Maintained at Hold with Decreased Target to $35 on, Wednesday, November 1st, 2023
- Jason Bednar of "Piper Sandler" Maintained at Hold with Decreased Target to $39 on, Friday, September 22nd, 2023
These are the ratings of the 2 analyists that currently disagree with Nathan
- Erin Wright of "Morgan Stanley" Maintained at Buy with Decreased Target to $39 on, Friday, November 3rd, 2023
- Michael Petusky of "Barrington Research" Maintained at Buy with Decreased Target to $41 on, Friday, November 3rd, 2023
Contributing Sources